Global Pediatric Medicines Market Outlook 2021

Global Pediatric Medicines Market Outlook 2021

Table of Contents
1 Pediatric Medicines Market Overview
1.1 Product Overview and Scope of Pediatric Medicines
1.2 Pediatric Medicines Segment by Type
1.2.1 Global Pediatric Medicines Sales Growth Rate Comparison by Type (2020-2026)
1.2.2 Enteral
1.2.3 Parenteral
1.2.4 Topical
1.3 Pediatric Medicines Segment by Application
1.3.1 Pediatric Medicines Sales Comparison by Application: (2020-2026)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Family
1.4 Global Pediatric Medicines Market Size Estimates and Forecasts
1.4.1 Global Pediatric Medicines Revenue 2015-2026
1.4.2 Global Pediatric Medicines Sales 2015-2026
1.4.3 Pediatric Medicines Market Size by Region: 2020 Versus 2026
2 Global Pediatric Medicines Market Competition by Manufacturers
2.1 Global Pediatric Medicines Sales Market Share by Manufacturers (2015-2020)
2.2 Global Pediatric Medicines Revenue Share by Manufacturers (2015-2020)
2.3 Global Pediatric Medicines Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Pediatric Medicines Manufacturing Sites, Area Served, Product Type
2.5 Pediatric Medicines Market Competitive Situation and Trends
2.5.1 Pediatric Medicines Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Pediatric Medicines Players (Opinion Leaders)
3 Pediatric Medicines Retrospective Market Scenario by Region
3.1 Global Pediatric Medicines Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Pediatric Medicines Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Pediatric Medicines Market Facts & Figures by Country
3.3.1 North America Pediatric Medicines Sales by Country
3.3.2 North America Pediatric Medicines Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Pediatric Medicines Market Facts & Figures by Country
3.4.1 Europe Pediatric Medicines Sales by Country
3.4.2 Europe Pediatric Medicines Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pediatric Medicines Market Facts & Figures by Region
3.5.1 Asia Pacific Pediatric Medicines Sales by Region
3.5.2 Asia Pacific Pediatric Medicines Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Pediatric Medicines Market Facts & Figures by Country
3.6.1 Latin America Pediatric Medicines Sales by Country
3.6.2 Latin America Pediatric Medicines Sales by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Pediatric Medicines Market Facts & Figures by Country
3.7.1 Middle East and Africa Pediatric Medicines Sales by Country
3.7.2 Middle East and Africa Pediatric Medicines Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Pediatric Medicines Historic Market Analysis by Type
4.1 Global Pediatric Medicines Sales Market Share by Type (2015-2020)
4.2 Global Pediatric Medicines Revenue Market Share by Type (2015-2020)
4.3 Global Pediatric Medicines Price Market Share by Type (2015-2020)
4.4 Global Pediatric Medicines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Pediatric Medicines Historic Market Analysis by Application
5.1 Global Pediatric Medicines Sales Market Share by Application (2015-2020)
5.2 Global Pediatric Medicines Revenue Market Share by Application (2015-2020)
5.3 Global Pediatric Medicines Price by Application (2015-2020)
6 Company Profiles and Key Figures in Pediatric Medicines Business
6.1 GSK
6.1.1 Corporation Information
6.1.2 GSK Description, Business Overview
6.1.3 GSK Pediatric Medicines Sales, Revenue and Gross Margin (2015-2020)
6.1.4 GSK Products Offered
6.1.5 GSK Recent Development
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description, Business Overview
6.2.3 Novartis Pediatric Medicines Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Novartis Products Offered
6.2.5 Novartis Recent Development
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description, Business Overview
6.3.3 Pfizer Pediatric Medicines Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Pfizer Products Offered
6.3.5 Pfizer Recent Development
6.4 Sanofi
6.4.1 Sanofi Corporation Information
6.4.2 Sanofi Description, Business Overview
6.4.3 Sanofi Pediatric Medicines Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Sanofi Products Offered
6.4.5 Sanofi Recent Development
6.5 Abbott
6.5.1 Abbott Corporation Information
6.5.2 Abbott Description, Business Overview
6.5.3 Abbott Pediatric Medicines Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Abbott Products Offered
6.5.5 Abbott Recent Development
6.6 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Corporation Information
6.6.2 Bristol-Myers Squibb Description, Business Overview
6.6.3 Bristol-Myers Squibb Pediatric Medicines Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Bristol-Myers Squibb Products Offered
6.6.5 Bristol-Myers Squibb Recent Development
6.7 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description, Business Overview
6.6.3 Cipla Pediatric Medicines Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Cipla Products Offered
6.7.5 Cipla Recent Development
6.8 Eisai Pharmaceuticals
6.8.1 Eisai Pharmaceuticals Corporation Information
6.8.2 Eisai Pharmaceuticals Description, Business Overview
6.8.3 Eisai Pharmaceuticals Pediatric Medicines Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Eisai Pharmaceuticals Products Offered
6.8.5 Eisai Pharmaceuticals Recent Development
6.9 Eli Lilly
6.9.1 Eli Lilly Corporation Information
6.9.2 Eli Lilly Description, Business Overview
6.9.3 Eli Lilly Pediatric Medicines Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Eli Lilly Products Offered
6.9.5 Eli Lilly Recent Development
6.10 F. Hoffman-La Roche
6.10.1 F. Hoffman-La Roche Corporation Information
6.10.2 F. Hoffman-La Roche Description, Business Overview
6.10.3 F. Hoffman-La Roche Pediatric Medicines Sales, Revenue and Gross Margin (2015-2020)
6.10.4 F. Hoffman-La Roche Products Offered
6.10.5 F. Hoffman-La Roche Recent Development
6.11 Glenmark
6.11.1 Glenmark Corporation Information
6.11.2 Glenmark Pediatric Medicines Description, Business Overview
6.11.3 Glenmark Pediatric Medicines Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Glenmark Products Offered
6.11.5 Glenmark Recent Development
6.12 Helsinn Healthcare
6.12.1 Helsinn Healthcare Corporation Information
6.12.2 Helsinn Healthcare Pediatric Medicines Description, Business Overview
6.12.3 Helsinn Healthcare Pediatric Medicines Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Helsinn Healthcare Products Offered
6.12.5 Helsinn Healthcare Recent Development
6.13 Heron Therapeutics
6.13.1 Heron Therapeutics Corporation Information
6.13.2 Heron Therapeutics Pediatric Medicines Description, Business Overview
6.13.3 Heron Therapeutics Pediatric Medicines Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Heron Therapeutics Products Offered
6.13.5 Heron Therapeutics Recent Development
6.14 Ipca Laboratories
6.14.1 Ipca Laboratories Corporation Information
6.14.2 Ipca Laboratories Pediatric Medicines Description, Business Overview
6.14.3 Ipca Laboratories Pediatric Medicines Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Ipca Laboratories Products Offered
6.14.5 Ipca Laboratories Recent Development
7 Pediatric Medicines Manufacturing Cost Analysis
7.1 Pediatric Medicines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pediatric Medicines
7.4 Pediatric Medicines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pediatric Medicines Distributors List
8.3 Pediatric Medicines Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Pediatric Medicines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pediatric Medicines by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Pediatric Medicines by Type (2021-2026)
10.2 Pediatric Medicines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pediatric Medicines by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Pediatric Medicines by Application (2021-2026)
10.3 Pediatric Medicines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pediatric Medicines by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Pediatric Medicines by Region (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Pediatric Medicines Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Pediatric Medicines Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Pediatric Medicines Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Pediatric Medicines Manufacturers Covered in This Study
Table 5. Global Pediatric Medicines Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Pediatric Medicines Sales Share by Manufacturers (2015-2020)
Table 7. Global Pediatric Medicines Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Pediatric Medicines Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Pediatric Medicines Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Pediatric Medicines Sales Sites and Area Served
Table 11. Manufacturers Pediatric Medicines Product Types
Table 12. Global Pediatric Medicines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Pediatric Medicines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Medicines as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Pediatric Medicines Players
Table 16. Global Pediatric Medicines Sales (K Units) by Region (2015-2020)
Table 17. Global Pediatric Medicines Sales Market Share by Region (2015-2020)
Table 18. Global Pediatric Medicines Revenue (Million US$) by Region (2015-2020)
Table 19. Global Pediatric Medicines Revenue Market Share by Region (2015-2020)
Table 20. North America Pediatric Medicines Sales by Country (2015-2020) (K Units)
Table 21. North America Pediatric Medicines Sales Market Share by Country (2015-2020)
Table 22. North America Pediatric Medicines Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Pediatric Medicines Revenue Market Share by Country (2015-2020)
Table 24. Europe Pediatric Medicines Sales by Country (2015-2020) (K Units)
Table 25. Europe Pediatric Medicines Sales Market Share by Country (2015-2020)
Table 26. Europe Pediatric Medicines Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Pediatric Medicines Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Pediatric Medicines Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Pediatric Medicines Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Pediatric Medicines Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Pediatric Medicines Revenue Market Share by Region (2015-2020)
Table 32. Latin America Pediatric Medicines Sales by Country (2015-2020) (K Units)
Table 33. Latin America Pediatric Medicines Sales Market Share by Country (2015-2020)
Table 34. Latin America Pediatric Medicines Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Pediatric Medicines Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Pediatric Medicines Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Pediatric Medicines Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Pediatric Medicines Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Pediatric Medicines Revenue Market Share by Country (2015-2020)
Table 40. Global Pediatric Medicines Sales (K Units) by Type (2015-2020)
Table 41. Global Pediatric Medicines Sales Share by Type (2015-2020)
Table 42. Global Pediatric Medicines Revenue (Million US$) by Type (2015-2020)
Table 43. Global Pediatric Medicines Revenue Share by Type (2015-2020)
Table 44. Global Pediatric Medicines Price (USD/Unit) by Type (2015-2020)
Table 45. Global Pediatric Medicines Sales (K Units) by Application (2015-2020)
Table 46. Global Pediatric Medicines Sales Market Share by Application (2015-2020)
Table 47. Global Pediatric Medicines Sales Growth Rate by Application (2015-2020)
Table 48. GSK Corporation Information
Table 49. GSK Description and Business Overview
Table 50. GSK Pediatric Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. GSK Main Product
Table 52. GSK Recent Development
Table 53. Novartis Corporation Information
Table 54. Novartis Description and Business Overview
Table 55. Novartis Pediatric Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Novartis Main Product
Table 57. Novartis Recent Development
Table 58. Pfizer Corporation Information
Table 59. Pfizer Description and Business Overview
Table 60. Pfizer Pediatric Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Pfizer Main Product
Table 62. Pfizer Recent Development
Table 63. Sanofi Corporation Information
Table 64. Sanofi Description and Business Overview
Table 65. Sanofi Pediatric Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Sanofi Main Product
Table 67. Sanofi Recent Development
Table 68. Abbott Corporation Information
Table 69. Abbott Description and Business Overview
Table 70. Abbott Pediatric Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Abbott Main Product
Table 72. Abbott Recent Development
Table 73. Bristol-Myers Squibb Corporation Information
Table 74. Bristol-Myers Squibb Description and Business Overview
Table 75. Bristol-Myers Squibb Pediatric Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Bristol-Myers Squibb Main Product
Table 77. Bristol-Myers Squibb Recent Development
Table 78. Cipla Corporation Information
Table 79. Cipla Description and Business Overview
Table 80. Cipla Pediatric Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Cipla Main Product
Table 82. Cipla Recent Development
Table 83. Eisai Pharmaceuticals Corporation Information
Table 84. Eisai Pharmaceuticals Description and Business Overview
Table 85. Eisai Pharmaceuticals Pediatric Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Eisai Pharmaceuticals Main Product
Table 87. Eisai Pharmaceuticals Recent Development
Table 88. Eli Lilly Corporation Information
Table 89. Eli Lilly Description and Business Overview
Table 90. Eli Lilly Pediatric Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Eli Lilly Main Product
Table 92. Eli Lilly Recent Development
Table 93. F. Hoffman-La Roche Corporation Information
Table 94. F. Hoffman-La Roche Description and Business Overview
Table 95. F. Hoffman-La Roche Pediatric Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. F. Hoffman-La Roche Main Product
Table 97. F. Hoffman-La Roche Recent Development
Table 98. Glenmark Corporation Information
Table 99. Glenmark Description and Business Overview
Table 100. Glenmark Pediatric Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Glenmark Main Product
Table 102. Glenmark Recent Development
Table 103. Helsinn Healthcare Corporation Information
Table 104. Helsinn Healthcare Description and Business Overview
Table 105. Helsinn Healthcare Pediatric Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Helsinn Healthcare Main Product
Table 107. Helsinn Healthcare Recent Development
Table 108. Heron Therapeutics Corporation Information
Table 109. Heron Therapeutics Description and Business Overview
Table 110. Heron Therapeutics Pediatric Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Heron Therapeutics Main Product
Table 112. Heron Therapeutics Recent Development
Table 113. Ipca Laboratories Corporation Information
Table 114. Ipca Laboratories Description and Business Overview
Table 115. Ipca Laboratories Pediatric Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Ipca Laboratories Main Product
Table 117. Ipca Laboratories Recent Development
Table 118. Production Base and Market Concentration Rate of Raw Material
Table 119. Key Suppliers of Raw Materials
Table 120. Pediatric Medicines Distributors List
Table 121. Pediatric Medicines Customers List
Table 122. Pediatric Medicines Market Trends
Table 123. Pediatric Medicines Opportunities and Drivers
Table 124. Pediatric Medicines Market Challenges
Table 125. Global Pediatric Medicines Sales (K Units) Forecast by Type (2021-2026)
Table 126. Global Pediatric Medicines Sales Market Share Forecast by Type (2021-2026)
Table 127. Global Pediatric Medicines Revenue (Million US$) Forecast by Type (2021-2026)
Table 128. Global Pediatric Medicines Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 129. Global Pediatric Medicines Sales (K Units) Forecast by Application (2021-2026)
Table 130. Global Pediatric Medicines Revenue (Million US$) Forecast by Application (2021-2026)
Table 131. Global Pediatric Medicines Sales (K Units) Forecast by Region (2021-2026)
Table 132. Global Pediatric Medicines Sales Market Share Forecast by Region (2021-2026)
Table 133. Global Pediatric Medicines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Global Pediatric Medicines Revenue Market Share Forecast by Region (2021-2026)
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Pediatric Medicines
Figure 2. Global Pediatric Medicines Sales Market Share by Type: 2020 VS 2026
Figure 3. Enteral Product Picture
Figure 4. Parenteral Product Picture
Figure 5. Topical Product Picture
Figure 6. Global Pediatric Medicines Consumption Market Share by Application: 2020 VS 2026
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Family
Figure 10. Global Pediatric Medicines Market Size 2015-2026 (US$ Million)
Figure 11. Global Pediatric Medicines Sales Capacity (K Units) (2015-2026)
Figure 12. Global Pediatric Medicines Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Pediatric Medicines Sales Share by Manufacturers in 2020
Figure 14. Global Pediatric Medicines Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pediatric Medicines Revenue in 2019
Figure 16. Pediatric Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Pediatric Medicines Sales Market Share by Region (2015-2020)
Figure 18. Global Pediatric Medicines Sales Market Share by Region in 2019
Figure 19. Global Pediatric Medicines Revenue Market Share by Region (2015-2020)
Figure 20. Global Pediatric Medicines Revenue Market Share by Region in 2019
Figure 21. North America Pediatric Medicines Sales Market Share by Country in 2019
Figure 22. North America Pediatric Medicines Revenue Market Share by Country in 2019
Figure 23. U.S. Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 24. U.S. Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 26. Canada Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe Pediatric Medicines Sales Market Share by Country in 2019
Figure 28. Europe Pediatric Medicines Revenue Market Share by Country in 2019
Figure 29. Germany Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 30. Germany Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 32. France Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.K. Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 36. Italy Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 38. Russia Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific Pediatric Medicines Sales Market Share by Region in 2019
Figure 40. Asia Pacific Pediatric Medicines Revenue Market Share by Region in 2019
Figure 41. China Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 42. China Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 44. Japan Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 46. South Korea Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 48. India Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 50. Australia Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 52. Taiwan Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 54. Indonesia Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 56. Thailand Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 58. Malaysia Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 60. Philippines Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 62. Vietnam Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America Pediatric Medicines Sales Market Share by Country in 2019
Figure 64. Latin America Pediatric Medicines Revenue Market Share by Country in 2019
Figure 65. Mexico Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 66. Mexico Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Brazil Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 68. Brazil Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Argentina Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Middle East and Africa Pediatric Medicines Sales Market Share by Country in 2019
Figure 72. Middle East and Africa Pediatric Medicines Revenue Market Share by Country in 2019
Figure 73. Turkey Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 74. Turkey Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Saudi Arabia Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 76. Saudi Arabia Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. U.A.E Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 78. U.A.E Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Sales Market Share of Pediatric Medicines by Type (2015-2020)
Figure 80. Sales Market Share of Pediatric Medicines by Type in 2020
Figure 81. Global Pediatric Medicines Market Share by Price Range (2015-2020)
Figure 82. Revenue Market Share of Pediatric Medicines by Type in 2019
Figure 83. Global Pediatric Medicines Sales Growth by Type (2015-2020) (K Units)
Figure 84. Sales Market Share of Pediatric Medicines by Application (2015-2020)
Figure 85. Sales Market Share of Pediatric Medicines by Application in 2020
Figure 86. Revenue Share of Pediatric Medicines by Application (2015-2020)
Figure 87. Revenue Share of Pediatric Medicines by Application in 2020
Figure 88. Key Raw Materials Price Trend
Figure 89. Manufacturing Cost Structure of Pediatric Medicines
Figure 90. Manufacturing Process Analysis of Pediatric Medicines
Figure 91. Pediatric Medicines Industrial Chain Analysis
Figure 92. Channels of Distribution
Figure 93. Distributors Profiles
Figure 94. Porter's Five Forces Analysis
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs